Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Trading Down 4.4% – What’s Next?

Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX)’s stock price traded down 4.4% on Friday . The stock traded as low as $15.60 and last traded at $15.62. 3,839 shares were traded during trading, a decline of 79% from the average session volume of 18,023 shares. The stock had previously closed at $16.34.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on TLX. William Blair upgraded Telix Pharmaceuticals Limited American Depositary Shares to a “strong-buy” rating in a research note on Tuesday, November 19th. UBS Group started coverage on Telix Pharmaceuticals Limited American Depositary Shares in a research note on Friday, November 15th. They issued a “buy” rating and a $21.00 price objective for the company.

Telix Pharmaceuticals Limited American Depositary Shares Stock Performance

Telix Pharmaceuticals Limited American Depositary Shares Company Profile

Telix Pharmaceuticals Limited is a biopharmaceutical company which focused on the development and commercialisation of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It involved in developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases.